Abstract
Patients who receive a donor lymphocyte infusion (DLI) for the treatment of relapsed leukemia after allogeneic BMT (alloBMT) often developed GVHD. To determine whether cytokines might have a role in GVHD, an intensive kinetic analysis of in vivo cytokine gene expression was performed on PBMC from three such patients. Expression of IL-1β, IL-2, IFN-γ, IL-4, IL-5, IL-8, IL-10, IL-12, TNF-α, and IL-2Rα was examined using a sensitive semi-quantitative reverse transcription (RT)-PCR assay system. Six normal controls were also analyzed for comparison. Expression of type 1 T helper (Th1) cytokines, IL-2 and IFN-γ was greatly increased in all three patients. In particular, the changes in IL-2 gene expression correlated well with disease progression, suggesting that IL-2 has a critical role in the development of GVHD. Although the pattern of type 2 T helper (Th2) cytokine gene expression differed in each patient, the expression of IL-4 was inversely related to expression of Th1 cytokines. These results suggest that Th1 dominates in the development of human clinical GVHD. Bone Marrow Transplantation (2001) 27, 373–380.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Storb R, Thomas ED . Graft-versus-host disease in dog and man: the Seattle experience Immunol Rev 1985 88: 215–238
Klimpel GR, Annable CR, Cleveland MG et al. Immunosuppression and lymphoid hypoplasia associated with chronic graft-versus-host disease is dependent upon IFN-gamma production J Immunol 1990 144: 84–93
Symington FW, Pepe MS, Chen AB, Deliganis A . Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans Transplantation 1990 50: 518–521
Holler E, Kolb HJ, Moller A et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation Blood 1990 75: 1011–1016
McCarthy PL Jr, Abhyankar S, Neben S et al. Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease Blood 1991 78: 1915–1918
Ferrara JLM, Deeg HJ . Graft-versus-host disease New Engl J Med 1991 324: 667–674
Antin JH, Ferrara JL . Cytokine dysregulation and acute graft-versus-host disease Blood 1992 80: 2964–2968
Ferrara JL . The cytokine modulation of acute graft-versus-host disease Bone Marrow Transplant 1998 21: (Suppl. 3) S13–S15
Mosmann TR, Cherwinski H, Bond MW et al. Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins J Immunol 1986 136: 2348–2357
Salgame P, Abrams JS, Clayberger C et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones Science 1991 254: 279–282
SAllen JE, Maizels RM . Th1-Th2: reliable paradigm or dangerous dogma? Immunol Today 1997 18: 387–392
Garlisi CG, Pennline KJ, Smith SR et al. Cytokine gene expression in mice undergoing chronic graft-versus-host disease Mol Immunol 1993 30: 669–677
Imoto S, Oomato Y, Murata K et al. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease Int J Haematol 2000 72: 92–97
Allen RD, Staley TA, Sidman CL . Differential cytokine expression in acute and chronic murine graft-versus-host disease Eur J Immunol 1993 23: 333–337
Baker KS, Allen RD, Roths JB, Sidman CL . Kinetic and organ-specific patterns of cytokine expression in acute graft-versus-host disease Bone Marrow Transplant 1995 15: 595–603
Siegert W, Josimovic-Alasevic O, Schwerdtfeger R et al. Soluble interleukin 2 receptors in patients after bone marrow transplantation Bone Marrow Transplant 1990 6: 97–101
Herve P, Wijdenes J, Bergerat JP et al. Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) Blood 1990 75: 1017–1023
Anasetti C, Martin PJ, Hansen JA et al. A phase I–II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease Transplantation 1990 50: 49–54
Blaise D, Olive D, Hirn M et al. Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patients Bone Marrow Transplant 1991 8: 105–111
Anasetti C, Hansen JA, Waldmann TA et al. Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor Blood 1994 84: 1320–1327
Tanaka J, Imamura M, Kasai M et al. Cytokine gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation Br J Haematol 1993 85: 558–565
Carayol G, Bourhis JH, Guillard M et al. Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host disease Transplantation 1997 63: 1307–1313
Roy J, Blazar BR, Ochs L, Weisdorf DJ . The tissue expression of cytokines in human acute cutaneous graft-versus-host disease Transplantation 1995 60: 343–348
Mowat AM . Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction Immunology 1989 68: 18–23
Brok HP, Heidt PJ, van der Meide PH et al. Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice J Immunol 1993 151: 6451–6459
Murphy WJ, Welniak LA, Taub DD et al. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice J Clin Invest 1998 102: 1742–1748
Fowler DH, Kurasawa K, Smith R et al. Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice Blood 1994 84: 3540–3549
Tanaka J, Imamura M, Kasai M et al. The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease Bone Marrow Transplant 1997 19: 571–576
Hempel L, Korholz D, Nussbaum P et al. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation Bone Marrow Transplant 1997 20: 365–368
Takatsuka H, Takemoto Y, Okamoto T et al. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation Bone Marrow Transplant 1999 24: 1005–1007
Xun CQ, Thompson JS, Jennings CD et al. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice Blood 1994 83: 2360–2367
Remberger M, Ringden O, Markling L . TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD Bone Marrow Transplant 1995 15: 99–104
Remberger M, Ringden O . Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver Eur J Haematol 1997 59: 254–262
Gibson UE, Heid CA, Williams PM . A novel method for real time quantitative RT-PCR Genome Res 1996 6: 995–1001
Acknowledgements
The authors are grateful to Ms I Ushio and Ms K Miki for their excellent technical assistance.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Das, H., Imoto, S., Murayama, T. et al. Kinetic analysis of cytokine gene expression in patients with GVHD after donor lymphocyte infusion. Bone Marrow Transplant 27, 373–380 (2001). https://doi.org/10.1038/sj.bmt.1702799
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702799
Keywords
This article is cited by
-
Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusion
Bone Marrow Transplantation (2005)